Literature DB >> 21048560

Outbreaks following wild poliovirus importations --- Europe, Africa, and Asia, January 2009-September 2010.

.   

Abstract

The Global Polio Eradication Initiative (GPEI) began in 1988. By 2006, indigenous transmission of wild poliovirus (WPV) had been interrupted in all but four countries (Afghanistan, India, Nigeria, and Pakistan). However, outbreaks following WPV importations into previously polio-free countries remain an ongoing risk until polio is eradicated. The GPEI Strategic Plan for 2010-2012 set the following two goals for outbreak control: 1) end outbreaks occurring in 2009 by mid-2010 and 2) end outbreaks occurring during 2010 to mid-2012 within 6 months of confirmation. This report describes new outbreaks that have occurred in the World Health Organization (WHO) European Region and updates previous reports on the status of outbreaks in Africa and Asia. In 2010, the first WPV importation into the European Region since the region was declared polio-free in 2002 resulted in 476 confirmed cases: 458 in Tajikistan, 14 in Russia, three in Turkmenistan, and one in Kazakhstan. In Africa and Asia, 11 new importations into six countries were observed in 2010; 30 WPV importations that occurred during 2008-2009 resulted in 215 cases in 15 African countries during 2009-2010. An outbreak is considered interrupted if 6 months have elapsed since the latest confirmed case and surveillance performance indicators meet WHO standards. All 2009 outbreaks in Africa appear to have been interrupted, and 2010 outbreaks in three countries appear to have been interrupted. Maintaining high routine vaccination coverage and sensitive surveillance at all times and rapidly instituting additional immunization programs to control outbreaks are key to limiting and stopping the spread of WPV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048560

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  31 in total

Review 1.  Polio elimination in Nigeria: A review.

Authors:  Usman Nakakana Nasir; Ananda Sankar Bandyopadhyay; Francesca Montagnani; Jacqueline Elaine Akite; Etaluka Blanche Mungu; Ifeanyi Valentine Uche; Ahmed Mohammed Ismaila
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Professor Natan Goldblum and the combined vaccination program in Gaza.

Authors:  Ted Tulchinsky
Journal:  Am J Public Health       Date:  2011-05       Impact factor: 9.308

3.  Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011.

Authors:  Nicksy Gumede; Jaume Jorba; Jagadish Deshpande; Mark Pallansch; Riziki Yogolelo; Jean Jacques Muyembe-Tamfum; Olen Kew; Marietjie Venter; Cara C Burns
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

4.  An outbreak of wild poliovirus in the Republic of Congo, 2010-2011.

Authors:  Minal K Patel; Mandy Kader Konde; Boris Hermann Didi-Ngossaki; Edouard Ndinga; Riziki Yogolelo; Mbaye Salla; Keith Shaba; Johannes Everts; Gregory L Armstrong; Danni Daniels; Cara Burns; Steve Wassilak; Mark Pallansch; Katrina Kretsinger
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

5.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

6.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

7.  Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

Authors:  Carla Magda Allan S Domingues; Sirlene de Fátima Pereira; Ana Carolina Cunha Marreiros; Nair Menezes; Brendan Flannery
Journal:  J Infect Dis       Date:  2014-11-01       Impact factor: 5.226

8.  Rapid simultaneous detection of enterovirus and parechovirus RNAs in clinical samples by one-step real-time reverse transcription-PCR assay.

Authors:  Susan Bennett; Heli Harvala; Jeroen Witteveldt; E Carol McWilliam Leitch; Nigel McLeish; Kate Templeton; Rory Gunson; William F Carman; Peter Simmonds
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

9.  Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.

Authors:  Cara C Burns; Jing Shaw; Jaume Jorba; David Bukbuk; Festus Adu; Nicksy Gumede; Muhammed Ali Pate; Emmanuel Ade Abanida; Alex Gasasira; Jane Iber; Qi Chen; Annelet Vincent; Paul Chenoweth; Elizabeth Henderson; Kathleen Wannemuehler; Asif Naeem; Rifqiyah Nur Umami; Yorihiro Nishimura; Hiroyuki Shimizu; Marycelin Baba; Adekunle Adeniji; A J Williams; David R Kilpatrick; M Steven Oberste; Steven G Wassilak; Oyewale Tomori; Mark A Pallansch; Olen Kew
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

10.  Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Authors:  Beatriz T Costa-Carvalho; Kathleen E Sullivan; Patrícia M Fontes; Fernanda Aimé-Nobre; Isabela G S Gonzales; Elaine S Lima; Celso Granato; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2018-07-14       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.